-
Exxaro Tiles Expands Its Footprint
In keeping with Exxaro Tiles Ltd’s upward growth trajectory, there have been positive developments regarding the company’s performance. Ca
-
What's next for Windlas Biotech, Devyani after listing?
Shares of Exxaro Tiles closed at Rs 132.20, at a premium of 10.16% compared with the issue price of Rs 120 per share
-
Book listing gains in Exxaro Tiles
Book profits in Exxaro Tiles as the peers like Somany Ceramics and Kajaria Ceramics may outperform the company in the long run.
-
Exxaro Tiles shares list at 5% premium over issue price
The Rs 161.08 crore public offer received bids for 25,96,52,625 shares against 1,14,50,675 shares on offer, as per an update on the exchanges
-
Check GMPs allotment status for Devyani International, Krsnaa Diagnostics, Exxaro Tiles, Windlas Biotech IPOs
Here is the grey market premium for Devyani International Rs 56, Krsnaa Diagnostics Rs 290, Exarro Tiles Rs 9 and Windlas Biotech Rs 90
-
Female participation rises in IPOs: Paytm Money
Devyani International saw the highest share of applications from Paytm Money investors under 25 years of age
-
Day 2: Exxaro Tiles IPO subscribed 10.29 times
The IPO received bids for 11,78,80,500 shares against 1,14,50,675 shares on offer
-
Four new IPOs leave investors spoilt for choice; which one should you pick for your portfolio?
Krsnaa Diagnostics, Devyani International, Exxaro Tiles and Windlas Biotech are going to raise close to Rs 3,614 crore between August 4 and 6
-
Exxaro Tiles IPO: Retail portion oversubscribed on Day 1
The public offer has received bids for 1,32,93,375 shares till 11.20 am (IST) against 1,14,50,675 shares offered by the company
-
Exxaro Tiles IPO opens tomorrow; should you subscribe?
Exxaro Tiles: At the upper end of the price band, the IPO will fetch Rs 161.08 crore
